707 related articles for article (PubMed ID: 8336186)
1. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
Brodeur GM; Pritchard J; Berthold F; Carlsen NL; Castel V; Castelberry RP; De Bernardi B; Evans AE; Favrot M; Hedborg F
J Clin Oncol; 1993 Aug; 11(8):1466-77. PubMed ID: 8336186
[TBL] [Abstract][Full Text] [Related]
2. Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
Liang WH; Federico SM; London WB; Naranjo A; Irwin MS; Volchenboum SL; Cohn SL
JCO Clin Cancer Inform; 2020 Oct; 4():895-905. PubMed ID: 33058692
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma image-defined risk factors in adrenal neuroblastoma: role of radiologist.
Lanza C; Galeazzi V; Carboni N; De Berardinis A; De Marino L; Barile A; Giovagnoni A
Gland Surg; 2019 Sep; 8(Suppl 3):S168-S177. PubMed ID: 31559184
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma: biology and therapy.
Matthay KK
Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma.
Castleberry RP
Eur J Cancer; 1997 Aug; 33(9):1430-7; discussion 1437-8. PubMed ID: 9337686
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
[TBL] [Abstract][Full Text] [Related]
7. Control of apoptosis and mitotic spindle checkpoint by survivin.
Li F; Ambrosini G; Chu EY; Plescia J; Tognin S; Marchisio PC; Altieri DC
Nature; 1998 Dec; 396(6711):580-4. PubMed ID: 9859993
[TBL] [Abstract][Full Text] [Related]
8. NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network.
O'Reilly R; Cheung NK; Bowman L; Castle V; Hoffer F; Kapoor N; Kletzel M; Lindsley K; Shamberger R; Tubergen D
Oncology (Williston Park); 1996 Dec; 10(12):1813-22. PubMed ID: 8985966
[No Abstract] [Full Text] [Related]
9. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Ladanyi M; Gerald WL
J Clin Oncol; 1996 Jul; 14(7):2174-80. PubMed ID: 8683252
[TBL] [Abstract][Full Text] [Related]
10. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate.
Hsu LL; Evans AE; D'Angio GJ
Med Pediatr Oncol; 1996 Dec; 27(6):521-8. PubMed ID: 8888811
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
12. SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma.
Prathipati P; Pathania AS; Chaturvedi NK; Gupta SC; Byrareddy SN; Coulter DW; Challagundla KB
Mol Ther Nucleic Acids; 2024 Jun; 35(2):101543. PubMed ID: 38817681
[TBL] [Abstract][Full Text] [Related]
13. Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients.
Nakatani N; Win KHN; Mon CY; Fujikawa T; Uemura S; Saito A; Ishida T; Mori T; Hasegawa D; Kosaka Y; Inoue S; Nishimura A; Nino N; Tamura A; Yamamoto N; Nozu K; Nishimura N
Biology (Basel); 2024 May; 13(5):. PubMed ID: 38785826
[TBL] [Abstract][Full Text] [Related]
14.
Qian LD; Zhou ZA; Li SQ; Liu J; Zhang SX; Ren JL; Wang W; Yang J
Quant Imaging Med Surg; 2024 Apr; 14(4):3131-3145. PubMed ID: 38617169
[TBL] [Abstract][Full Text] [Related]
15. Bilateral adrenal neuroblastoma: peculiar pattern of a rare pediatric presentation.
Fawzy M; Ahmed G; Youssef Y; Elkinaai N; Refaat A; Elahmadawy MA; Said F; Elmenawi S
Discov Oncol; 2024 Apr; 15(1):115. PubMed ID: 38607453
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
17. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report.
Kompani F; Safari Sharari A; Haji Esmaeil Memar E; Ghahremanloo M
Arch Iran Med; 2024 Jan; 27(1):44-47. PubMed ID: 38431960
[TBL] [Abstract][Full Text] [Related]
18. Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
Amano H; Uchida H; Harada K; Narita A; Fumino S; Yamada Y; Kumano S; Abe M; Ishigaki T; Sakairi M; Shirota C; Tainaka T; Sumida W; Yokota K; Makita S; Karakawa S; Mitani Y; Matsumoto S; Tomioka Y; Muramatsu H; Nishio N; Osawa T; Taguri M; Koh K; Tajiri T; Kato M; Matsumoto K; Takahashi Y; Hinoki A
Cancer Sci; 2024 May; 115(5):1634-1645. PubMed ID: 38411285
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow relapse in stage 4 neuroblastoma of children in Shanghai.
Li H; Zhao J; Yang J; Tang J; Zhang T; Jiang H; Shao J
Am J Cancer Res; 2024; 14(1):145-154. PubMed ID: 38323287
[TBL] [Abstract][Full Text] [Related]
20. Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review.
Jahangiri L
Med Sci (Basel); 2024 Jan; 12(1):. PubMed ID: 38249081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
